Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUmeå University

About this trial

This observational study aims to evaluate the implementation and use of the Tät®II app for the treatment of urgency and mixed urinary incontinence in women over the age of 18 after contact with ordinary healthcare, as well as its effectiveness. The study aims to answer the following question:

Is treatment via the app effective and feasible after primary care?

Participants will use the app for 15 weeks to treat urgency and mixed urinary incontinence. They will answer online survey questions about their urinary incontinence before, after 15 weeks, and one year after treatment.

Eligibility criteria

Qualifiers

Female gender

Age ≥18 years

Symptoms of urgency urinary incontinence or mixed urinary incontinence

Medical evaluation and documentation of urinary incontinence by ordinary doctor

Disqualifiers

Pregnancy

Childbirth in the last 6 months

Painful urges

Difficulties emptying the bladder

Trial design

Treatments tested in this trial

  • Tät®II

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Umeå University

Lead sponsor

Region Jämtland Härjedalen

Collaborator